Heartware (HTWR) Sees Q4 Revenue of $68M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
JPMorgan Downgrades Heartware International (HTWR) to Neutral
January 12, 2016 11:06 AM ESTJPMorgan earlier downgraded Heartware International (NASDAQ: HTWR) from Overweight to Neutral with a price target of $39.00 (from $56.00).
For an analyst ratings summary and ratings history on Heartware International click here. For more ratings news on Heartware International click here.
Shares of Heartware International closed at $40.84 yesterday.
... MoreLeerink Affirms HeartWare (HTWR) at 'Outperform' Amid Prelim. Q4 Numbers, ENDURANCE Ambitions
January 12, 2016 8:50 AM ESTLeerink reaffirms HeartWare International, Inc. (Nasdaq: HTWR) at Outperform with a price target of $60 after the company announced preliminary results Monday night.
Analyst Danielle Antalffy commented, ...though yet another MVAD delay appears to be negative, HTWR is submitting its ENDURANCE trial data for... More
